Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)

Laboratory Investigation

Volumn 79, Issue 11, 1999, Pages 1385-1392

  Prince, Gregory A ^a   Prieels, Jean Paul ^b   Slaoui, Moncef ^b   Porter, David D ^c  

^a Virion Systems Inc   (United States)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; BRONCHITIS; CONTROLLED STUDY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLITIS; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SAFETY; VACCINATION; VASCULITIS; VIRUS INFECTION;

ANIMALS; BRONCHIOLITIS; BRONCHITIS; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; PULMONARY ALVEOLI; RATS; RECURRENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGMODONTINAE; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0032707699     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aherne W, Bird T, Court SDM, Gardner PS, and McQuillin J (1970). Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 23:7-18.
2. Chin J, Magoffin RL, Shearer LA, Schieble JH, and Lennette EH (1969). Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89:449-463.
3. Collins PL, McIntosh K, and Chanock RM (1996). Respiratory syncytial virus. In: Fields BN, Knipe DM, Howley, PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven, 1313-1351.
4. Connors M, Giese NA, Kulkarni AB, Firestone C-Y, Morse HC, and Murphy BR (1994). Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68:5321-5325.
5. Connors M, Kulkarni AB, Firestone C-Y, Holmes KL, Morse HC, Sotnikov AV, and Murphy BR (1992). Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol 66:7444-7451.
6. Dreizin RS, Vyshnevetskaya LO, Bagdamyan EE, Yankevich OD, Tarasova LB, and Klenova AV (1971). Study of experimental RS virus infection in cotton rats: Virologic and immunofluorescent studies. Vopr Virusol 16:670-676.
7. Dudas RA and Karron RA (1998). Respiratory syncytial virus vaccines. Clin Microbiol Rev 11:430-439.
8. Falsey AR (1998). Respiratory syncytial virus infection in older persons. Vaccine 16:1775-1778.
9. Fixler DE (1996). Respiratory syncytial virus infection in children with congenital heart disease: A review. Pediatr Cardiol 17:163-168.
10. Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, and Meiklejohn G (1969). Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alumprecipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435-448.
11. Gershwin LJ, Schelegle ES, Gunther RA, Anderson ML, Woolums AR, Larochelle DR, Boyle GA, Friebertshauser KE, and Singer RS (1998). A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 16: 1225-1236.
12. Ginsberg HS, Horswood RL, Chanock RM, and Prince GA (1990). Role of early genes in pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 87:6191-6195.
13. Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM, and Prince GA (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 88:1651-1655.
14. Graham BS, Bunton LA, Wright PF, and Karzon DT (1991). Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88:1026-1033.
15. Graham BS, Henderson GS, Tang Y-W, Lu X, Neuzil KM, and Colley DG (1993). Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 151:2032-2040.
16. Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, and Hemming VG (1993). Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 329:1524-1530.
17. Hall CB, Walsh EE, Long CE, and Schnabel KC (1991). Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698.
18. Henderson FW, Collier AM, Clyde WA, and Denny FW (1979). Respiratory syncytial virus infections, reinfections and immunity. N Engl J Med 300:530-534.
19. Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang S-C, Dormitzer M, O'Grady J, Koenig S, Tamura JK, Woods R, Bansal G, Couchenour D, Tsao E, Hall WC, and Young JF (1997). Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 176:1215-1224.
20. Kakuk TJ, Soike K, Brideau RJ, Zaya RM, Cole SL, Zhang J-Y, Roberts ED, Wells PA, and Wathen MW (1993). A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J Infect Dis 167:553-561.
21. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, and Stewart CE (1969). An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421.
22. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, and Parrott RH (1969). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422-434.
23. McIntosh K and Fishaut JM (1980). Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol 26:94-118.
24. PREVENT Study Group (1997). Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99: 93-99.
25. Prince GA, Hemming VG, Horswood RL, and Chanock RM (1985a). Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res 3:193-206.
26. Prince GA, Horswood RL, Camargo E, Koenig D, and Chanock RM (1983). Mechanisms of immunity to respiratory syncytial virus in cotton rats. Infect Immun 42:81-87.
27. Prince GA, Horswood RL, and Chanock RM (1985b). Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol 55:517-520.
28. Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, and Chanock RM (1986). Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by intramuscular inoculation of formalin-inactivated virus. J Virol 57:721-728.
29. Prince GA, Jenson AB, Horswood RL, Camargo E, and Chanock RM (1978). The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol 93:771-791.
30. Prince GA, Porter DD, Jenson AB, Horswood RL, Chanock RM, and Ginsberg HS (1993). The pathogenesis of type 5 adenovirus pneumonia in cotton rats (Sigmodon hispidus). J Virol 67:101-111.
31. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, and Kunkel SL (1996). The good, the bad, and the ugly:The role of chemokines in models of human disease. J Immunol 156:3583-3586.
32. Waris ME, Tsou C, Erdman DD, Zaki SR, and Anderson LJ (1996). Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like pattern. J Virol 70:2852-2860.
33. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N, Yousuf H, Tarrand JJ, and Bodey GP (1996). Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22:778-782.